Oncogene - Table of Contents alert Volume 37 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 3 (March 2018) In this issue Review Original Articles Oncogenomics Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe Review Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma   Oncogene 2017 37 : 277 - 285; September 25, 2017; 10.1038/onc.2017.343   Abstract | Full Text Original Articles ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways F Wang, A Y Wang, C Chesnelong, Y Yang, A Nabbi et al. Oncogene 2017 37 : 286 - 301; September 18, 2017; 10.1038/onc.2017.324   Abstract | Full Text A slow-cycling subpopulation of melanoma cells with highly invasive properties M Perego, M Maurer, J X Wang, S Shaffer, A C Müller et al. Oncogene 2017 37 : 302 - 312; September 18, 2017; 10.1038/onc.2017.341   Abstract | Full Text Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis S Stelloo, E Nevedomskaya, Y Kim, L Hoekman, O B Bleijerveld et al. Oncogene 2017 37 : 313 - 322; September 18, 2017; 10.1038/onc.2017.330   Abstract | Full Text Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling L Xia, X Xiao, W L Liu, Y Song, T J J Liu et al. Oncogene 2017 37 : 323 - 331; September 18, 2017; 10.1038/onc.2017.342   Abstract | Full Text Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes G J Ortiz, Y Li, S M Post, V Pant, S Xiong et al. Oncogene 2017 37 : 332 - 340; September 18, 2017; 10.1038/onc.2017.344   Abstract | Full Text PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy X Bian, J Gao, F Luo, C Rui, T Zheng et al. Oncogene 2017 37 : 341 - 351; September 25, 2017; 10.1038/onc.2017.326   Abstract | Full Text RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells H Youn, H-K Lee, H-R Sohn, U-H Park, E-J Kim et al. Oncogene 2017 37 : 352 - 362; September 25, 2017; 10.1038/onc.2017.329   Abstract | Full Text Oncogenic RAS-induced CK1a drives nuclear FOXO proteolysis F Zhang, D M Virshup & J K Cheong Oncogene 2017 37 : 363 - 376; September 25, 2017; 10.1038/onc.2017.334   Abstract | Full Text ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma M R Yun, H M Choi, H N Kang, Yw Lee, H-S Joo et al. Oncogene 2017 37 : 377 - 388; September 25, 2017; 10.1038/onc.2017.339   Abstract | Full Text Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms L-N Fu, Y-Q Wang, J Tan, J Xu, Q-Y Gao et al. Oncogene 2017 37 : 389 - 402; September 25, 2017; 10.1038/onc.2017.345   Abstract | Full Text Oncogenomics Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment A B Nagaraj, Q Q Wang, P Joseph, C Zheng, Y Chen et al. Oncogene 2017 37 : 403 - 414; October 02, 2017; 10.1038/onc.2017.328   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.